Our professionals
Dr. Macarena Rodríguez
Specialist in Nuclear Medicine.
Special focus: Molecular imaging applied to oncology and radiometabolic therapies. Hepatic radioembolization with yttrium-90 microspheres in liver tumors, personalized dosimetry, and PET/CT with ⁶⁸Ga-PSMA and ¹¹C-choline in prostate cancer.
Works at:
Navarre headquarters
Be part of:
Clínica Universidad de Navarra
Cancer Center Clínica Universidad de Navarra
INDEX H
20
Professional career
She graduated in Medicine from the University of Cádiz in 1999. She specialized in Nuclear Medicine at the Clínica Universidad de Navarra. She received her PhD in Medicine from the University of Navarra in 2011.
Clinical Consultant in the Nuclear Medicine Department at the Clínica Universidad de Navarra, where she has carried out her clinical, teaching, and research activity for more than 20 years.
Between September 2025 and June 2026, she completed a research stay at Massachusetts General Hospital, Harvard Medical School, in the area of Radiopharmaceutical Therapy, Radiobiology and Radioembolization —Bertolet Lab—.
RESEARCH AREAS
- Molecular imaging applied to oncology.
- Radiometabolic therapies and personalized dosimetry.
- Hepatic radioembolization with yttrium-90 microspheres.
- Optimization of hepatic radioembolization using computational simulation models.
- Development of predictive models in prostate cancer using molecular imaging.
- PET/CT with ⁶⁸Ga-PSMA and ¹¹C-choline in prostate cancer.
AREAS OF INTEREST
- Radioembolization of liver tumors with ⁹⁰Y-labeled microspheres.
- PET/CT with ⁶⁸Ga-PSMA in prostate cancer.
- PET/CT with ¹¹C-choline in initial prostate carcinoma and in recurrence after treatment with curative intent.
- Personalized dosimetry in radiometabolic therapies.
- Nuclear Medicine and Molecular Imaging.
- Bone densitometry.
- Breast cancer.
Activity
In teaching
- Associate Professor at the School of Medicine of the University of Navarra.
- Tutor of Nuclear Medicine Residents since 2013.
- She collaborates in the training of specialists and in national and international teaching activities in the field of Nuclear Medicine and Molecular Imaging.
In research
- She has participated in national and international projects and has more than 130 scientific publications.
- Her main lines of research focus on the optimization of hepatic radioembolization with yttrium-90 microspheres, including the FIS PI18/00692 project on the optimization of hepatic radioembolization using a computational simulation model, and on the development of predictive models in prostate cancer using molecular imaging.
- She has been an invited speaker at more than 40 national and international courses and conferences. She has participated as an invited speaker at leading conferences such as the European Association of Nuclear Medicine congress, where she delivered a lecture in the Marie Curie plenary session on PSMA PET in prostate cancer, as well as a continuing education session on hepatic radioembolization. She was also an invited speaker at the European Congress of Radiology 2025, addressing the role of PSMA PET in the management of prostate cancer.
Scientific organizations
- President of the Oncology Group of the Spanish Society of Nuclear Medicine and Molecular Imaging.
- Member of the European Association of Nuclear Medicine.
- Chair of the Piloting Group on patient inclusion at the European Association of Nuclear Medicine since 2023.
- Expert collaborator of the International Atomic Energy Agency in international training programs.